Sensitive detection of lysosomal membrane permeabilization by lysosomal galectin puncta assay S Aits, J Kricker, B Liu, AM Ellegaard, S Hämälistö, S Tvingsholm, ... Autophagy 11 (8), 1408-1424, 2015 | 377 | 2015 |
Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma NP Kristensen, C Heeke, SA Tvingsholm, A Borch, A Draghi, ... The Journal of clinical investigation 132 (2), 2022 | 87 | 2022 |
Proton pump inhibitor use and cancer mortality SA Tvingsholm, C Dehlendorff, K Østerlind, S Friis, M Jäättelä International journal of cancer 143 (6), 1315-1326, 2018 | 52 | 2018 |
Release of transcriptional repression via ErbB2-induced, SUMO-directed phosphorylation of myeloid zinc finger-1 serine 27 activates lysosome redistribution and invasion DM Brix, SA Tvingsholm, MB Hansen, KB Clemmensen, T Ohman, V Siino, ... Oncogene 38 (17), 3170-3184, 2019 | 21 | 2019 |
Let-7 microRNA controls invasion-promoting lysosomal changes via the oncogenic transcription factor myeloid zinc finger-1 SA Tvingsholm, MB Hansen, KKB Clemmensen, DM Brix, B Rafn, ... Oncogenesis 7 (2), 14, 2018 | 20 | 2018 |
Novel molecular targets for hepatocellular carcinoma B Cavalluzzo, A Mauriello, C Ragone, C Manolio, ML Tornesello, ... Cancers 14 (1), 140, 2021 | 9 | 2021 |
Identification of lysosome‐targeting drugs with anti‐inflammatory activity as potential invasion inhibitors of treatment resistant HER2 positive cancers MB Hansen, M Postol, S Tvingsholm, IØ Nielsen, TN Dietrich, P Puustinen, ... Cellular Oncology 44 (4), 805-820, 2021 | 8 | 2021 |
Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer G van der Horst, AF van de Merbel, E Ruigrok, MH van der Mark, E Ploeg, ... Molecular oncology 14 (12), 3121-3134, 2020 | 8 | 2020 |
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy SA Tvingsholm, MS Frej, VM Rafa, UK Hansen, M Ormhøj, A Tyron, ... Journal for immunotherapy of cancer 11 (8), 2023 | 5 | 2023 |
Dynamics of Melanoma-associated EPITOPE-specific Cd8+ T cells in the blood correlate with clinical outcome under PD-1 blockade A Gaißler, TS Meldgaard, C Heeke, S Babaei, SA Tvingsholm, J Bochem, ... Frontiers in Immunology 13, 906352, 2022 | 4 | 2022 |
Increased mortality in patients with hematologic malignancies treated with proton pump inhibitors: A nationwide cohort study A Vilmar, C Dehlendorff, S Friis, M Jäättelä, S Tvingsholm, H Frederiksen Leukemia & Lymphoma 64 (8), 1451-1457, 2023 | 3 | 2023 |
T antigen–specific CD8+ T cells associate with PD-1 blockade response in virus-positive Merkel cell carcinoma UK Hansen, CD Church, AMC Simões, MS Frej, AK Bentzen, ... The Journal of Clinical Investigation 134 (8), 2024 | 1 | 2024 |
IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition A Borch, I Carri, B Reynisson, HMG Alvarez, KK Munk, A Montemurro, ... Frontiers in Immunology 15, 1360281, 2024 | 1 | 2024 |
Neoepitope-specific CD8+ T cells in adoptive T-cell transfer NP Kristensen, C Heeke, SA Tvingsholm, AM Bjerregaard, A Draghi, ... Cancer Immunology Research 8 (3), 38-38, 2020 | 1 | 2020 |
Cross-reactive CD8+ T cell responses to tumor-associated antigens (TAAs) and homologous microbiota-derived antigens (MoAs) B Cavalluzzo, MC Viuff, SA Tvingsholm, C Ragone, C Manolio, ... Journal of Experimental & Clinical Cancer Research 43 (1), 87, 2024 | | 2024 |
55P Neoantigen-reactive CD8 T-cells experience broadened and activated recognition profile following PD-L1 blockade and 1000-fold neoantigen-specific expansion using ImmPACT … JS Holm, SA Funt, SA Tvingsholm, A Borch, DF Bajorin, SR Hadrup Annals of Oncology 32, S1395, 2021 | | 2021 |
Abstract A14: Neoepitope-specific CD8+ T cells in adoptive T-cell transfer NP Kristensen, C Heeke, SA Tvingsholm, AM Bjerregaard, A Draghi, ... Cancer Immunology Research 8 (3_Supplement), A14-A14, 2020 | | 2020 |
Molecular and Transcriptional Signatures for ErbB2-Induced Invasion SA Tvingsholm, DM Brix, T Kallunki Current Pharmacology Reports 5, 43-55, 2019 | | 2019 |